6533b7d4fe1ef96bd1262eac

RESEARCH PRODUCT

The impact of tumor nitric oxide production on VEGFA expression and tumor growth in a zebrafish rat glioma xenograft model.

Nadhir YousfiBenoist PruvotTatiana LopezLea MagadouxNathalie FrancheLaurent PichonFrançoise SalvadoriEric SolaryCarmen GarridoVéronique LaurensJohanna Chluba

subject

Vascular Endothelial Growth Factor AMESH: Cyclin D1lcsh:MedicineMESH : Analysis of VarianceMESH: Flow Cytometry[ SDV.IMM.IA ] Life Sciences [q-bio]/Immunology/Adaptive immunologyBenzoates[SDV.IMM.II]Life Sciences [q-bio]/Immunology/Innate immunity[ SDV.CAN ] Life Sciences [q-bio]/CancerMESH: GliomaMESH: Reverse Transcriptase Polymerase Chain ReactionCyclin D1MESH: Animalslcsh:ScienceZebrafishMESH : RatsReverse Transcriptase Polymerase Chain ReactionMESH: Real-Time Polymerase Chain ReactionHistological TechniquesMESH : Reverse Transcriptase Polymerase Chain ReactionImidazolesGliomaMESH: Gene Expression Regulation NeoplasticFlow CytometryMESH : Cyclin D1Gene Expression Regulation NeoplasticMESH : Nitric Oxide[SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunologyMESH : Vascular Endothelial Growth Factor AHeterograftsMESH : Histological TechniquesMESH: ImidazolesResearch ArticleMESH : BenzoatesMESH: RatsMESH : Flow CytometryMESH : Gene Expression Regulation NeoplasticMESH : Real-Time Polymerase Chain ReactionMESH : Zebrafish[SDV.CAN]Life Sciences [q-bio]/CancerMESH: Histological TechniquesMESH : HeterograftsNitric OxideReal-Time Polymerase Chain ReactionMESH : ImidazolesMESH: Analysis of VarianceAnimalsMESH: Zebrafish[ SDV.IMM.II ] Life Sciences [q-bio]/Immunology/Innate immunityAnalysis of VarianceMESH: Vascular Endothelial Growth Factor Alcsh:RMESH: BenzoatesRatsMESH : GliomaMESH: Nitric Oxidelcsh:QMESH: HeterograftsMESH : Animals

description

International audience; To investigate the effect of nitric oxide on tumor development, we established a rat tumor xenograft model in zebrafish embryos. The injected tumor cells formed masses in which nitric oxide production could be detected by the use of the cell-permeant DAF-FM-DA (diaminofluorophore 4-amino-5-methylamino-2'-7'-difluorofluorescein diacetate) and DAR-4M-AM (diaminorhodamine-4M). This method revealed that nitric oxide production could be co-localized with the tumor xenograft in 46% of the embryos. In 85% of these embryos, tumors were vascularized and blood vessels were observed on day 4 post injection. Furthermore, we demonstrated by qRT-PCR that the transplanted glioma cells highly expressed Nos2, Vegfa and Cyclin D1 mRNA. In the xenografted embryos we also found increased zebrafish vegfa expression. Glioma and zebrafish derived Vegfa and tumor Cyclin D1 expression could be down regulated by the nitric oxide scavenger 2-(4-Carboxyphenyl)-4,4,5,5-tetramethylimidazoline-1-oxyl-3-oxide or CPTIO. We conclude that even if there is a heterogeneous nitric oxide production by the xenografted glioma cells that impacts Vegfa and Cyclin D1 expression levels, our results suggest that reduction of nitric oxide levels by nitric oxide scavenging could be an efficient approach to treat glioma.

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01446713